Makoto Ide, MD, PhD, is a chief director in the second Department of Hematology at Takamatsu Red Cross Hospital in Japan. He has over 20 years experience in the diagnosis and treatment of Castleman disease and has published several articles about CD, including the use of rituximab and steroid therapy in HIV-negative MCD.
Scientific Advisory Board